+D Messenger RNA Biogenesis KO #

  Prokaryotic Defense System - Aliivibrio fischeri MJ11

% ! ACRISPR-Cas system B Universal Cas proteins B Type I CRISPR-Cas system C Type I signiture cas proteins C Subtype I-A factors C Subtype I-B factors C Subtype I-C factors C Subtype I-D factors C Subtype I-E factors C Subtype I-F factors D VFMJ11_1056 conserved hypothetical protein K19128 csy2; CRISPR-associated protein Csy2 D VFMJ11_1055 csy_2; crispr-associated protein, Csy3 family K19129 csy3; CRISPR-associated protein Csy3 D VFMJ11_1054 csy_1; crispr-associated protein, Csy4 family K19130 csy4; CRISPR-associated endonuclease Csy4 [EC:3.1.-.-] C Subtype I-U factors B Type II CRISPR-Cas system C Type II signiture cas proteins C Subtype II-A factors C Subtype II-B factors B Type III CRISPR-Cas system C Type III signiture cas proteins C Subtype III-A factors C Subtype III-B factors C Subtype III-U factors # ARestriction and modification system (R-M system) B Type I R-M system C VFMJ11_2141 type I restriction-modification system, R subunit K01153 hsdR; type I restriction enzyme, R subunit [EC:3.1.21.3] C VFMJ11_B0055 type I site-specific deoxyribonuclease K01153 hsdR; type I restriction enzyme, R subunit [EC:3.1.21.3] C VFMJ11_B0054 restriction modification system S subunit K01154 hsdS; type I restriction enzyme, S subunit [EC:3.1.21.3] C VFMJ11_2142 restriction modification system DNA specificity domain protein K01154 hsdS; type I restriction enzyme, S subunit [EC:3.1.21.3] C VFMJ11_2143 type I restriction-modification system, M subunit K03427 hsdM; type I restriction enzyme M protein [EC:2.1.1.72] C VFMJ11_B0053 type I restriction-modification system, M subunit K03427 hsdM; type I restriction enzyme M protein [EC:2.1.1.72] B Type II R-M system C Restriction endonucleases C DNA methyltransferases D VFMJ11_2401 retron EC67 DNA adenine methylase K06223 dam; DNA adenine methylase [EC:2.1.1.72] B Type III R-M system B Type IV R-M system C VFMJ11_A0755 restriction endonuclease family K07448 mrr; restriction system protein # AToxin-antitoxin system (TA system) B Type I TA system C Hok-Sok C SymE-SymR C Ldr-Rdl C TisB-IstR C Ibs-Sib C ShoB-OhsC C RalR-RalA B Type II TA system C MazF-MazE C ChpB-ChpS C YhaV-PrlF C RelE/StbE-RelB/StbD D VFMJ11_A0688 toxin RelE K06218 relE; mRNA interferase RelE/StbE D VFMJ11_A0687 stability protein StbD, putative K18923 stbD; antitoxin StbD C YafQ-dinJ C YoeB-YefM C HipA-HipB D VFMJ11_1565 protein HipA K07154 hipA; serine/threonine-protein kinase HipA [EC:2.7.11.1] D VFMJ11_2144 HipA domain protein K07154 hipA; serine/threonine-protein kinase HipA [EC:2.7.11.1] D VFMJ11_1564 HTH-type transcriptional regulator HipB K15773 hipB; HTH-type transcriptional regulator / antitoxin HipB D VFMJ11_2145 putative transcriptional regulator, XRE family K15773 hipB; HTH-type transcriptional regulator / antitoxin HipB C HicA-HicB C YafO-YafN C Hha-TomB C PspC-PspB D VFMJ11_A0351 pspC; phage shock protein C K03973 pspC; phage shock protein C D VFMJ11_A0350 pspB; phage shock protein B K03970 pspB; phage shock protein B C CcdB-CcdA D VFMJ11_A0651 CcdB K19163 ccdB; toxin CcdB D VFMJ11_A0650 CcdB antidote CcdA K19164 ccdA; antitoxin CcdA C ParE-ParD D VFMJ11_A0880 toxin of toxin-antitoxin stability system K19092 parE1_3_4; toxin ParE1/3/4 C Doc-Phd C HigB-HigA D VFMJ11_A0657 plasmid maintenance system killer protein K07334 higB-1; toxin HigB-1 D VFMJ11_A0656 higA; addiction module antidote protein, HigA family K21498 higA-1; antitoxin HigA-1 C MqsR-MqsA C VapC-VapB C PezT-PezA C YobL-YobK C YokI-YokJ C YqcG-YqcF C YxiD-YxxD C FitB-FitA C BC_0920-BC_0921 C Type II TA system related factors D VFMJ11_A1008 conserved hypothetical protein K19334 tabA; biofilm protein TabA D VFMJ11_2309 ftsZ; cell division protein FtsZ K03531 ftsZ; cell division protein FtsZ D VFMJ11_0363 Rod shape-determining protein MreB K03569 mreB; rod shape-determining protein MreB and related proteins D VFMJ11_2338 parC; DNA topoisomerase IV, A subunit K02621 parC; topoisomerase IV subunit A [EC:5.6.2.2] D VFMJ11_2339 parE; DNA topoisomerase IV, B subunit K02622 parE; topoisomerase IV subunit B [EC:5.6.2.2] D VFMJ11_2020 gltX; glutamyl-tRNA synthetase K01885 EARS; glutamyl-tRNA synthetase [EC:6.1.1.17] B Type III TA system C AbiQ system B Type IV TA system C YeeV-YeeU C CptA-CptB D VFMJ11_2201 protein VV1_1557 K09159 cptB; antitoxin CptB B Type V TA system C GhoT-GhoS # ADNA phosphothiolation system B Sulfur modification proteins C VFMJ11_0631 iscS; cysteine desulfurase IscS K04487 iscS; cysteine desulfurase [EC:2.8.1.7] C VFMJ11_B0020 putative DGQHR domain protein K19169 dndB; DNA sulfur modification protein DndB C VFMJ11_A0171 dndB; DNA sulfur modification protein DndB K19169 dndB; DNA sulfur modification protein DndB C VFMJ11_A0170 dndC; putative sulfurtransferase DndC K19170 dndC; DNA sulfur modification protein DndC C VFMJ11_A0169 dndD; DNA sulfur modification protein DndD K19171 dndD; DNA sulfur modification protein DndD C VFMJ11_A0168 dndE; DNA sulfur modification protein DndE K19172 dndE; DNA sulfur modification protein DndE B DNA phosphorothioation-dependent restriction proteins C VFMJ11_A0163 dnd system-associated protein 3 K19173 dptF; DNA phosphorothioation-dependent restriction protein DptF C VFMJ11_A0164 dnd system-associated protein 1 K19174 dptG; DNA phosphorothioation-dependent restriction protein DptG C VFMJ11_A0165 dnd system-associated protein 2 K19175 dptH; DNA phosphorothioation-dependent restriction protein DptH ! #
#[ BRITE | KEGG2 | KEGG ]
#Last updated: November 7, 2023